期刊文献+

综合干预治疗慢性阻塞性肺疾病稳定期53例疗效观察 被引量:4

The survey of multiple treatments of chronic obstructive pulmonary disease stationary phase
下载PDF
导出
摘要 目的:探讨慢性阻塞性肺疾病(COPD)稳定期的治疗策略。方法:比较53例稳定期COPD患者综合干预前后患者呼吸困难程度的变化、6min步行距离(6MWD)、肺功能(FEV1)、体质量指数(BM I)的变化。结果:经过1年的综合干预,COPD干预前后6MWD和呼吸困难比较有显著性差异(P<0.05),但BM I和FEV1比较无显著性差异(P>0.05)。结论:综合干预对稳定期COPD的患者非常重要,可以明显改善患者生存质量,延缓肺功能进一步下降。 Objective: The discussion of how to choose therapeutic schedule of chronic obstructive pulmo- nary disease (COPD) stationary phase. Metheds:The comparing of the difficult breathing level, six minutes walk distance (6MWD), the frist second forced expiratory volume (FEV1) and body mass index (BMI) of the beginning and end of multple treat to 43 patients suffer from chrionic obstructive pulmonary disease stationary phase. Results: The comparings of six minutes walk test (6MWT) and difficult breathing level were statistics significance (P〈0. 05). The comparings of the frist second forced expiratory volume (FEV1) and body mass index (BMI) were not statistics significance (P 〉 0. 05). Conclusion: the multple treatments of chrionic obstructive pulmonary disease (COPD) stationary phase is very important, because of they can improve survival quality evidently of patients and postpone the process of pulmonary function declining.
出处 《陕西医学杂志》 CAS 2013年第1期21-22,42,共3页 Shaanxi Medical Journal
基金 中华医学会临床医学科研专项资金资助(No 08020750153)
关键词 肺疾病 慢性阻塞性 治疗 综合疗法 呼吸功能试验 Pulmonary disease,chronic obstructive/therapy Combined modality therapy Respiratory function tests
  • 相关文献

参考文献10

二级参考文献64

  • 1周敏,徐永健.慢性阻塞性肺疾病患者的营养支持治疗及存在的问题[J].中国实用内科杂志,2005,25(2):104-106. 被引量:54
  • 2张红,余丽君.慢性阻塞性肺疾病长期家庭氧疗依从性的研究进展[J].解放军护理杂志,2006,23(7):43-45. 被引量:20
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 4赵碧双,黄丹,魏惠灵,胥正川.长期氧疗在慢性阻塞性肺疾病缓解期疗效评价[J].四川医学,2007,28(7):733-734. 被引量:6
  • 5中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南.北京:中华医学会呼吸病学分会慢性阻塞性肺疾病学组,2002:460.
  • 6Hattotuwa KL, Gizycki M J, Ansari TW, et al. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study[J]. Am J Respir Crit Care Med, 2002, 165(7): 1592-1596.
  • 7Calverley P, Pauwels R, Vestboet J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease:a randomised controlled trial[J]. Lancet, 2003, 361(5):449-456.
  • 8NanniniL J Jr, Flores DM. Bronchodilator effect of zafirlukast in subjects with chronic obstructive pulmonary disease [J]. Pulm Phamacol Ther, 2003, 16 (7) :307-311.
  • 9Tug T, Karatas F, Terzi SM. Antioxidant vitamins (A, C and E ) and malondialdehyde levels in acute exacerbation and stable periods of patients with chronic obstructive pulmonary disease[J]. Clin Invest Mel,2004, 27(6):123-128.
  • 10Compton CH, Gubb J, Nieman R, et al. Cilomilast, a selective Phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease a randomised, dose-ranging study[J]. Lancet, 2001, 358(2):265-270.

共引文献136

同被引文献33

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1793
  • 3王锦鸿.新编常用中药手册[M].北京:金盾出版社,2001.12-13.
  • 4雷载权.中药学[M].上海:上海科学技术出版社,2002..
  • 5国家食品药品监督管理局.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002:226-230.
  • 6周仲瑛.中医内科学[M].2版.北京:中国中医药出版社,2007:379.
  • 7陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 8于勇.试论调气与治痰[J].陕西中医,2007,28(9):1198-1199. 被引量:10
  • 9郑筱萸.中药新药临床床指导原则[M].中国医药科技出版社,2000:57-58.
  • 10Weatherall M, Marsh S, Shirtcliffe P, et al. Quality of life measured by the St George's Respiratory Questionnaire and spirometry[J]. Eur Respir,2012,33(5): 1025 -1030.

引证文献4

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部